UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA
Clinical trials for UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Trial tests drug holiday for leukemia patients to reduce Long-Term risks
Disease control OngoingThis study is testing a new treatment schedule for older or frail adults with a type of blood cancer called chronic lymphocytic leukemia (CLL). All patients will first take the drug acalabrutinib for 18 months. Then, some will stop taking it to see if they can remain well without…
Matched conditions: UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: French Innovative Leukemia Organisation • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New pill challenges standard chemo for common adult leukemia
Disease control OngoingThis study is comparing a newer, targeted pill called acalabrutinib against a standard combination of chemotherapy and immunotherapy (chlorambucil plus rituximab) for adults with previously untreated chronic lymphocytic leukemia (CLL). It is for older adults or younger adults wit…
Matched conditions: UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC